Recent News

• 09.12.2025 - Alkermes Appoints Joshua Reed as Chief Financial Officer
• 09.12.2025 - Alkermes Appoints Joshua Reed as Chief Financial Officer
• 09.11.2025 - Alkermes Announces Launch of 8th Annual Alkermes Pathways Research Awards® Program
• 09.11.2025 - Alkermes Announces Launch of 8th Annual Alkermes Pathways Research Awards® Program
• 09.08.2025 - World Sleep 2025
• 09.08.2025 - World Sleep 2025
• 09.08.2025 - Alkermes Presents Detailed Positive Results from Vibrance-1 Phase 2 Study of Alixorexton in Patients with Narcolepsy Type 1 at World Sleep Congress 2025
• 09.08.2025 - Alkermes Presents Detailed Positive Results from Vibrance-1 Phase 2 Study of Alixorexton in Patients with Narcolepsy Type 1 at World Sleep Congress 2025
• 09.03.2025 - Benjamin Burnett
• 09.03.2025 - Benjamin Burnett

Recent Filings

• 09.12.2025 - 8-K Current report
• 09.12.2025 - 8-K Current report
• 09.12.2025 - EX-99.1 EX-99.1
• 09.08.2025 - 8-K Current report
• 09.08.2025 - EX-99.1 EX-99.1
• 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 08.04.2025 - 4 Statement of changes in beneficial ownership of securities